Contrasting US and European approaches to colorectal cancer screening: Which is best?

Gut

Volumn 59, Issue 3, 2010, Pages 407-414

  Hoff, Geir ^a   Dominitz, Jason A ^b  

^a TELEMARK HOSPITAL   (Norway)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; ECHOGRAPHY; HEALTH CARE ORGANIZATION; HUMAN; PRIORITY JOURNAL; REVIEW;

COLORECTAL NEOPLASMS; EUROPE; EVIDENCE-BASED MEDICINE; HUMANS; MASS SCREENING; PROGRAM EVALUATION; UNITED STATES;

EID: 77749306482     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.192948     Document Type: Review

References (89)

1. Hao Y, Jemal A, Zhang X, et al. Trends in colorectal cancer incidence rates by age, race/ethnicity, and indices of access to medical care, 1995-2004 (United States). Cancer Causes Control Published Online First 19 June 2009. doi: 10.1007/s10552-009-9379-y.
2. Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009;150:1-8.
3. Robertson DJ, Greenberg ER, Beach M, et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 2005;129:34-41.
4. Robertson DJ, Lieberman DA, Winawer SJ, et al. Interval cancer after total colonoscopy: results from a pooled analysis of eight studies. Gastroenterology 2008;134:A-111-2.
5. Pickhardt PJ, Nugent PA, Mysliwiec PA, et al. Location of adenomas missed by optical colonoscopy. Ann Intern Med 2004;141:352-9.
6. Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Gastrointest Endosc 2006;63(4 Suppl):S16-2.
7. Sieg A, Brenner H. Cost-saving analysis of screening colonoscopy in Germany. Z Gastroenterol 2007;45:945-51.
8. Zauber AG, Knudsen AB, Rutter CM, et al. DRAFT white paper: cost-effectiveness of ct colonography to screen for colorectal cancer. Technology Assessment. November 2008. Rockville, Maryland: Agency for Healthcare Research and Quality. http:// www.ahrq.gov/clinic/ta/tadctcc/ (accessed 30 Jun 2009).
9. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-92.
10. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
11. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occultblood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
12. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
13. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
14. Selby JV, Friedman GD, Quesenberry CP Jr, et al. A case - control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
15. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
16. Newcomb PA, Storer BE, Morimoto LM, et al. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst 2003;95:622-5.
17. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A caseecontrol study among veterans. Arch Intern Med 1995;155:1741-8.
18. Kavanagh AM, Giovannucci EL, Fuchs CS, et al. Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control 1998;9:455-62.
19. Weissfeld JL, Schoen RE, Pinsky PF, et al. PLCO Project Team. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst 2005;97:989-97.
20. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomized trial. Lancet 2002;359;1291-300.
21. Segnan N, Senore C, Andreoni B, et al. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy" - SCORE. J Natl Cancer Inst 2002;94:1763-72.
22. Hoff G, Grotmol T, Skovlund E, et al. Norwegian Colorectal Cancer Prevention Study Group. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 2009;338:b1846.
23. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-81.
24. Citarda F, Tomaselli G, Capocaccia R, et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001;48:812-5.
25. Kahi CJ, Imperiale TF, Juliar BE, et al. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 2009;7:770-5.
26. Müller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995;123:904-10.
27. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000;343:162-8.
28. Imperiale TF, Wagner DR, Lin CY, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000;343:169-74.
29. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Colorectal Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-14.
30. Ahlquist DA, Sargent DJ, Loprinzi CL, et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008;149:441-50.
31. Pickhardt PJ, Choi JR, Hwang I, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003;349:2191-200.
32. Johnson CD, Chen MH, Toledano AY, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008;359:1207-17.
33. Eddy D. ACS report on the cancer-related health checkup. CA Cancer J Clin 1980;30:193-240.
34. US Preventive Services Task Force. Guide to clinical preventive services, 2nd edn. Baltimore: Williams and Wilkins, 1996.
35. US Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 2002;137:129- 31.
36. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95.
37. US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2008:149:627-37.
38. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol 2009;104:739-50.
39. Pox C, SchmiegelW, Classen M. Current status of screening colonoscopy in Europe and in the United States. Endoscopy 2007;39:168-73.
40. European Commission. Council recommendation on cancer screening. http://ec.europa.eu/health/ph-determinants/genetics/ documents/com-2003-0230-en. pdf (accessed 19 Feb 2009).
41. Europe against colorectal cancer: declaration of Brussels, 9 May 2007. http://www.future-health-2007.com/index.php? id=15#c601 (accessed 19 Feb 2009).
42. IARC. Globocan 2002. http://www-dep.iarc.fr/ (accessed 19 Feb 2009).
43. Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006;355:1863-72.
44. Malila N, Anttila A, Hakama M. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004. J Med Screen 2005;12:28-32.
45. Malila N, Oivanen T, Malminiemi O, et al. Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. BMJ 2008;337:a2261 doi: 10.1136/bmj.a2261.
46. Cram P, Fendrick AM, Inadomi J, et al. The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med 2003;163:1601-5.
47. MMWR Morb Mortal Wkly Rep 2008;57:253-258.
48. Kussman MJ. VHA Directive 2007-004. Colorectal Cancer Screening. Washington, DC: Department of Veterans Affairs, Veterans Health Administration, 2007 20420.
49. Department of Veterans Affairs 2008 Organizational Briefing Book. http://www.va.gov/ofcadmin/docs/vaorgbb.pdf (accessed 5 May 2009).
50. El-Serag HB, Petersen L, Hampel H, et al. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. Arch Intern Med 2006;166:2202-8.
51. Department of Veterans Affairs Office of Quality and Performance. Quality of Care Indicators: VA-HEDIS Comparisons. OQP intranet. http://vaww.oqp.med.va.gov/ (limited access intranet site) (accessed 30 June 2009).
52. National Committee for Quality Assurance. The State of Health Care Quality 2008. www.ncqa.org/Portals/0/Newsroom/SOHC/ SOHC-08.pdf (accessed 30 Jun 2009).
53. Levin TR. Editorial: it's time to make organized colorectal cancer screening convenient and easy for patients. Am J Gastroenterol 2009;104:939-41.
54. Lieberman D. A call to action - measuring the quality of colonoscopy. N Engl J Med 2006;355:2588-9.
55. Meissner HI, Breen N, Klabunde CN, et al. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006;15:389-94.
56. Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol 2003;98:2082-91.
57. Thorner RM, Remein QR. Principles and Procedures in the Evaluation of Screening for Disease. PHS publication no. 846. Public Health Monograph no. 67. Washington: Public Health Service, 1961.
58. Wilson JMG, Jungner G. Principles of practice of screening for disease. Geneva: WHO, 1968.
59. UK National Screening Committee. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. http://www.nsc.nhs.uk/pdfs/criteria.pdf (accessed 11 Dec 2008).
60. Moayyedi P, Achkar E. Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data. Am J Gastroenterol 2006;101:380-4.
61. Larsen IK, Grotmol T, Almendingen K, et al. Impact of colorectal cancer screening on future lifestyle choices: a three-year randomized controlled trial. Clin Gastroenterol Hepatol 2007;5:477-83.
62. Petersen GM. Barriers to preventive intervention. Gastroenterol Clin North Am 2002;31:1061-8.
63. Dulai GS, Farmer MM, Ganz PA, et al. Primary care provider perceptions of barriers to and facilitators of colorectal cancer screening in a managed care setting. Cancer 2004;100:1843-52.
64. Tufts A. German patients escape financial penalties for not following their doctor's advice. Br Med J 2008;336:65.
65. World Health Organization National Cancer Control Programmes. Policies and managerial guidelines. 2nd edn. Geneva: World Health Organization, 2002. http://www.who.int/ cancer/media/en/408.pdf (accessed 30 Jun 2009).
66. Lord S, Irwig L, Simes RJ. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Ann Intern Med 2006;144:850-5.
67. Gondal G, Grotmol T, Hofstad B, et al. The Norwegian colorectal cancer prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol 2003;38:635-42.
68. NordICC- The Nordic-European Initiative on Colorectal cancer. http://www.kreftregisteret.no /NordICC/ (accessed 30 Jun 2009).
69. Graser A, Stieber P, Nagel D, et al. Comparison of CT colonosgraphy, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population. Gut 2009;58:241-8.
70. Brenner DJ, Hall EJ. Computed tomography - an increasing source of radiation exposure. N Engl J Med 2007;357:2277-84.
71. Tappenden P, Chilcott J, Eggington S, et al. Option appraisal of population-based colorectal cancer screening programmes in England. Gut 2007;56:677-84.
72. Hakama M, Coleman MP, Alexe DM, et al. Cancer screening: evidence and practice in Europe 2008. Eur J Cancer 2008;44:1404- 13.
73. Mauri D, Pentheroudakis G, Milousis A, et al. Colorectal cancer screening awareness in European primary care. Cancer Detect Prev 2006;30:75-82.
74. Weller D, Coleman D, Robertson R, et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer 2007;97:1601-5.
75. Goulard H, Boussac-Zarebska M, Ancelle-Park R, et al. French colorectal cancer screening pilot programme: results of the first round. J Med Screen 2008;15:143-8.
76. Grazzini G, Castiglione G, Ciabattoni C, et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev 2004;13:19-26.
77. Taylor KL, Shelby R, Gelmann E, et al. Quality of life and trial adherence among participants in the prostate, lung, colorectal and ovarian cancer screening trial. J Natl Cancer Inst 2004;96:1083-94.
78. Larson MF, Ko CW, Dominitz JA. Effectiveness of a provider reminder on fecal occult blood test follow-up. Dig Dis Sci 2009;54:991-6.
79. Singh H, Kadiyala H, Bhagwath G, et al. Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results. Am J Gastroenterol 2009;104:942-52.
80. Seeff LC, Manninen DL, Dong FB, et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology 2004;127:1661-9.
81. Taylor KM, Arajs K, Rouse T, et al. Prospective audit of colonoscopy quality in Kent and Medway, UK. Endoscopy 2008;40:291-5.
82. Hoff G, Bretthauer M, Huppertz-Hauss G, et al. The Norwegian Gastronet project: continuous improvement of colonoscopy in 14 Norwegian centres. Scand J Gastroenterol 2006;41:481-7.
83. Atkin W, Rogers P, Cardwell C, et al. Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. Gastroenterology 2004;126:1247-56.
84. Barclay RL, Vicari JJ, Doughty AS, et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 2006;355:2533-41.
85. Lieberman D, Nadel M, Smith RA, et al. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc 2007;65:757-65.
86. Selinger RR, Norman S, Dominitz JA. Failure of health care professionals to interpret fecal occult blood tests accurately. Am J Med 2003;114:64-7.
87. Dominitz JA, Robertson DJ. Colorectal cancer screening with computed tomographic colonography. Gastroenterology 2009;136:1451- 3.
88. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007;146:244-55.
89. Laiyemo AO, Pinsky PF, Marcus PM, et al. Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial. Clin Gastroenterol Hepatol 2009;7:562-7.